Saga Diagnostics logo

Saga Diagnostics

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

3

Funding Rounds

$20.4m

Money raised

Overview

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Funding

Funding series

Funding Series Analysis

The company Saga Diagnostics has raised a total of $20.4m in funding over 3 rounds.

Key Insights:

  • Saga Diagnostics June 2021 Series A Funding Round: $12m
  • SAGA , June 2019: $4.2m
  • Saga Diagnostics June 2019 Series A Funding Round: $4.2m
Saga Diagnostics logo
Saga Diagnostics June 2021 Series A Funding Round $12m
Saga Diagnostics logo
SAGA , June 2019 $4.2m
Saga Diagnostics logo
Saga Diagnostics June 2019 Series A Funding Round $4.2m

Industries

Saga Diagnostics is active in the following industries: